(19)
(11)
EP 1 150 677 A1
(12)
(43)
Date of publication:
07.11.2001
Bulletin 2001/45
(21)
Application number:
99963820.8
(22)
Date of filing:
10.12.1999
(51)
International Patent Classification (IPC)
7
:
A61K
31/44
,
A61K
31/557
(86)
International application number:
PCT/SE9902/315
(87)
International publication number:
WO 0035/448
(
22.06.2000
Gazette 2000/25)
(84)
Designated Contracting States:
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE
Designated Extension States:
AL LT LV MK RO SI
(30)
Priority:
14.12.1998
SE 9804314
(71)
Applicant:
AstraZeneca AB
151 85 Södertälje (SE)
(72)
Inventors:
EEK, Arne
S-151 85 Södertälje (SE)
JOSEFSSON, Lars
S-431 83 Mölndal (SE)
LUNDBERG, Per, Johan
S-431 83 Mölndal (SE)
PILBRANT, Ake
S-431 83 Mölndal (SE)
(54)
NEW PHARMACEUTICAL FORMULATION